Scientific Opinion on the substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophillus LA 104 and reducing intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 11, Issue 2, 2013, Pages

[No Author Info available]

Author keywords

Bifidobacterium longum LA 101; health claims; intestinal discomfort; Lactobacillus helveticus LA 102; Lactococcus lactis LA 103; Streptococcus thermophilus LA 104

Indexed keywords

EID: 85077558571     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2013.3085     Document Type: Article

References (1)

1. Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P, 2008. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroentérologie Clinique et Biologique, 32, 147–152.